Publication: A qualitative study on the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy
This research article, published in the Journal of Patient Reported Outcomes, describes the development of a conceptual model of the impact of nonsense mutation Duchenne muscular dystrophy (nmDMD) on caregivers, based on interviews with parents of patients with the condition
Review the methods used to conduct a qualitative study, interviewing 10 parents of patients with nmDMD
Explore the results evaluating the impact of nmDMD on caregivers of patients with the condition
Learn about a conceptual model to show the impact of caring for a patient with nmDMD, including social, emotional, physical, time, work, and relationship burdens
Williams K, Davidson I, Rance M, et al. J Pat-Rep Outcomes. 2021;5:71
▼ Ataluren is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system. Adverse events should also be reported to PTC at firstname.lastname@example.org.
Registration conditions differ internationally, and prescribing information may vary depending on local approval in each country. The European Summary of Product Characteristics for ataluren is available here. Please refer to your local country guidance for more information.
Once registered, you will be able to view the abstract and be provided the DOI and PubMed links for this publication.
Register now to unlock the content
Register now to access the content on this page
If not, register below
MED-ALL-DMD-2200033 | March 2022
Sign in or register to access exclusive content on this site